ORPHAZYME A/S |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,010 DKK | -7.76% |
|
+2.20% | -24.06% |
| Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Quotes 5-day view
Delayed Quote Nasdaq Copenhagen| 2024-05-02 | 2024-05-03 | 2024-05-06 | 2024-05-08 | |
|---|---|---|---|---|
| Last | 988.3 kr | 1097 kr | 1095 kr | 1010 kr |
| Volume | 10 | 53 | 12 | 6 |
| Change | -8.81% | +11.00% | -0.18% | -7.76% |
| Opening | 987.10 | 1,097.80 | 1,096.00 | 1,000.00 |
| High | 1,094.80 | 1,097.80 | 1,096.00 | 1,051.20 |
| Low | 987.10 | 989.10 | 989.60 | 1,000.00 |
Performance
| 1 day | -7.76% | ||
| 1 week | +2.20% | ||
| Current month | -8.17% | ||
| 1 month | -6.98% | ||
| 3 months | +4.15% | ||
| 6 months | +18.82% | ||
| Current year | -24.06% | ||
| 1 year | -14.41% | ||
| 3 years | -97.21% | ||
| 5 years | -98.12% |
Volumes
marketsDaily volume
6
Estimated daily volume
9
Avg. Volume 20 sessions
42
Daily volume ratio
0.21
Avg. Volume 20 sessions DKK
42 420.00
Avg. Volume 20 sessions USD
6 129.52
Record volume 1
16 795
Record volume 2
15 000
Record volume 3
10 208
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (DKK)
5 152 355
Capitalization (USD)
5 152 355
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
59.56 %
Free-Float capitalization (DKK)
3 068 914
Free-Float capitalization (USD)
3 068 914
Average Daily Capital Traded
0.82%
Highs and lows
1 week
989.60
1 096.00
1 month
951.501 119.80
Current year
850.001 400.00
1 year
407.005 370.00
3 years
407.00109 100.00
5 years
407.00137 500.00
10 years
407.00137 500.00
Indicators
Moving average 5 days
1 047.58
Moving average 20 days
1 073.76
Moving average 50 days
1 163.01
Moving average 100 days
1 194.11
Price spread / (MMA5)
+3.72%
Price spread / (MMA20)
+6.31%
Price spread / (MMA50)
+15.15%
Price spread / (MMA100)
+18.23%
STIM
RSI 9 days
51.83
RSI 14 days
49.33
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -7.76% | +2.20% | -24.06% | -14.41% | 5.15M | ||
| +0.04% | +4.71% | +2.97% | +21.51% | 108B | ||
| +1.28% | +3.24% | +10.21% | +28.23% | 104B | ||
| +1.00% | -1.73% | +2.59% | -3.03% | 22.33B | ||
| +2.14% | -0.20% | -12.77% | -12.06% | 22.19B | ||
| -0.45% | +2.93% | -7.05% | -25.54% | 18.69B | ||
| -1.15% | +2.70% | -38.36% | -32.55% | 17.74B | ||
| +2.55% | +4.09% | -6.50% | -31.36% | 17.64B | ||
| +0.46% | -0.12% | +6.00% | +43.62% | 14.05B | ||
| -0.21% | +1.28% | +37.20% | +5.53% | 12.51B | ||
| +0.36% | +5.86% | +330.95% | +257.24% | 8.84B | ||
| -0.44% | -0.89% | -24.35% | -32.93% | 8.28B | ||
| +0.55% | +5.01% | -50.47% | -67.60% | 7.77B | ||
| +0.57% | -0.68% | -0.24% | +28.85% | 7.71B | ||
| -0.60% | -5.65% | +5.70% | +36.97% | 7.61B | ||
| -1.83% | +1.58% | +4.41% | +23.00% | 7.13B | ||
| Average | -0.29% | +0.16% | +14.76% | +14.09% | ||
| Weighted average by Cap. | +0.59% | +2.21% | +8.29% | +15.99% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
30.4XcBlsI_hsjtM6_QCo2gnB2M-Bw7pG9oHtOjFwHYgYc.jURMwrt81L6LasiqerjFrG7IkW4CnB8lW6DbZGOexM-iAnfvrWa3kKFXlw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 10:01:50 am | 1,010 | 2 | 6 |
| 09:32:51 am | 1,010 | 1 | 4 |
| 06:55:48 am | 1,051 | 1 | 3 |
| 06:23:54 am | 1,029 | 1 | 2 |
Monthly variations
Annual change
| 2024 | -24.06% | ||
| 2023 | +51.14% | ||
| 2022 | -94.87% | ||
| 2021 | -74.43% | ||
| 2020 | -7.32% | ||
| 2019 | +67.01% | ||
| 2018 | -42.96% | ||
| 2017 | -5.00% |
- Stock Market
- Equities
- ORPHA Stock
- Quotes Orphazyme A/S